Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elsa M Villarino, MD, MPH
Centers for Disease Control and Prevention
Study Director - Timothy Sterling, MD
Vanderbilt University Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universidade Federal Do Rio de Janeiro
Rio de Janeiro, Brazil
- University of British Columbia
Vancouver, British Columbia, Canada
- University of Manitoba
Winnipeg, Manitoba, Canada
- Montreal Chest Institute Mcgill University
Montreal, Quebec, Canada
- Agencia de Salut Publica
Barcelona, Spain
- Central Arkansas Veterans Health System
Little Rock, Arkansas, United States
- la County/usc Medical Center
Los Angeles, California, United States
- Ucsd Medical Center
San Diego, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Denver Department of Public Health and Hospitals
Denver, Colorado, United States
- Washington, D.C. Vamc
Washington D.C., District of Columbia, United States
- Emory University, Department of Medicine
Atlanta, Georgia, United States
- Chicago Va Medical Center (lakeside)
Chicago, Illinois, United States
- Hines Va Medical Center
Hines, Illinois, United States
- Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- New Jersey Medical School
Newark, New Jersey, United States
- Columbia University/presbyterian Medical Center
New York, New York, United States
- Harlem Hospital Center
New York, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of North Texas Health Science Center
Fort Worth, Texas, United States
- Michael Debakey Veterans Affairs Medical Center
Houston, Texas, United States
- Audi L. Murphy Va Hospital
San Antonio, Texas, United States
- Seattle King County Health Department
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2001
- Primary completion
- 31 Oct 2010
- Completion
- 30 Sept 2013
- Last update posted
- 27 Aug 2024
- Registered enrollment
- 8,053
- Registry id
- NCT00023452
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.